JP2582736B2 - Periodontal disease growth inhibitor - Google Patents
Periodontal disease growth inhibitorInfo
- Publication number
- JP2582736B2 JP2582736B2 JP2126331A JP12633190A JP2582736B2 JP 2582736 B2 JP2582736 B2 JP 2582736B2 JP 2126331 A JP2126331 A JP 2126331A JP 12633190 A JP12633190 A JP 12633190A JP 2582736 B2 JP2582736 B2 JP 2582736B2
- Authority
- JP
- Japan
- Prior art keywords
- periodontal disease
- oil
- application example
- weight
- growth inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000028169 periodontal disease Diseases 0.000 title claims description 23
- 239000003966 growth inhibitor Substances 0.000 title claims description 11
- 241000894006 Bacteria Species 0.000 claims description 15
- 240000000513 Santalum album Species 0.000 claims description 5
- 235000008632 Santalum album Nutrition 0.000 claims description 5
- 239000000341 volatile oil Substances 0.000 claims description 5
- 240000002505 Pogostemon cablin Species 0.000 claims description 4
- 235000011751 Pogostemon cablin Nutrition 0.000 claims description 4
- 241000147041 Guaiacum officinale Species 0.000 claims description 3
- 229940091561 guaiac Drugs 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 description 16
- 239000010671 sandalwood oil Substances 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 13
- 239000000203 mixture Substances 0.000 description 9
- 235000015218 chewing gum Nutrition 0.000 description 8
- 229940112822 chewing gum Drugs 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 241001135221 Prevotella intermedia Species 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000021552 granulated sugar Nutrition 0.000 description 6
- 239000001927 guaiacum sanctum l. gum oil Substances 0.000 description 6
- 239000001738 pogostemon cablin oil Substances 0.000 description 6
- 241001135223 Prevotella melaninogenica Species 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000605862 Porphyromonas gingivalis Species 0.000 description 4
- 208000007565 gingivitis Diseases 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 241000606749 Aggregatibacter actinomycetemcomitans Species 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 238000001256 steam distillation Methods 0.000 description 3
- 241000935112 Bulnesia Species 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 241000605986 Fusobacterium nucleatum Species 0.000 description 2
- 240000001972 Gardenia jasminoides Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000008312 Tooth Loss Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000013022 formulation composition Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000008601 oleoresin Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- HFGHRUCCKVYFKL-UHFFFAOYSA-N 4-ethoxy-2-piperazin-1-yl-7-pyridin-4-yl-5h-pyrimido[5,4-b]indole Chemical compound C1=C2NC=3C(OCC)=NC(N4CCNCC4)=NC=3C2=CC=C1C1=CC=NC=C1 HFGHRUCCKVYFKL-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 241000331120 Krameria cistoidea Species 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241001521901 Tribulus lanuginosus Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- AYOOGWWGECJQPI-NSHDSACASA-N n-[(1s)-1-(5-fluoropyrimidin-2-yl)ethyl]-3-(3-propan-2-yloxy-1h-pyrazol-5-yl)imidazo[4,5-b]pyridin-5-amine Chemical compound N1C(OC(C)C)=CC(N2C3=NC(N[C@@H](C)C=4N=CC(F)=CN=4)=CC=C3N=C2)=N1 AYOOGWWGECJQPI-NSHDSACASA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- KMIOJWCYOHBUJS-HAKPAVFJSA-N vorolanib Chemical compound C1N(C(=O)N(C)C)CC[C@@H]1NC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C KMIOJWCYOHBUJS-HAKPAVFJSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Confectionery (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Fats And Perfumes (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は歯周病及び歯肉炎の発症と進行に深く関与し
ているバクテロイデス・ジンジバリス(Ba−cteroides
gingivalis),バクテロイデス・インターメディウス
(B.intermedius),バクテロイデス・メラニノジェニ
カス(B.melaninogenicus),アクチノバシラス・アク
チノマイセテムコミタンス(Ac−tinobacillus actinom
ycetemcomitans),フゾバクテリウム・ヌクレアタム
(Fusobacterium nucleatum)等に代表される各種口腔
内細菌に対して優れた抗菌作用を示す、歯周病菌増殖抑
制剤に関するものである。The present invention relates to Ba-cteroides, which is deeply involved in the development and progression of periodontal disease and gingivitis.
gingivalis), Bacteroides intermedius (B. intermedius), Bacteroides melaninogenicus (B. melaninogenicus), Actinobacillus actinomycetemcomitans (Ac-tinobacillus actinom)
The present invention relates to a periodontal disease growth inhibitor which exhibits an excellent antibacterial action against various oral bacteria represented by ycetemcomitans), Fusobacterium nucleatum and the like.
(従来の技術) 歯周病は歯肉炎が進行して起こるものであり、歯を失
う原因の50%が歯周病である。20代後半から歯周病の罹
患率は高くなり、中高年にかけては、約50%の人が(歯
肉炎をいれると80%)罹患している。一般的に歯周病の
発症と進行に歯肉溝内プラーク中のグラム陰性嫌気性桿
菌が深くかかわっているとされている。とりわけバクテ
ロイデス・ジンジバリス(B.gingivalis),バクテロイ
デス・インターメディウス(B.intermedius),バクテ
ロイデス・メラニノジェニカス(B.melaninogenicu
s),アクチノバシラス・アクチノマイセテムコミタン
ス(Actinobacillus actinomycetemcomitans),フゾバ
クテリウム・ヌクレアタム(Fusobacterium nucleatu
m)等が、種々のタイプの歯周病の発症,進行に関連し
ている可能性が示唆されている(中島光一ら:歯周病の
抗生物質治療.日歯周誌,29巻2号463−471,1987)。そ
れ故、歯周病の発症と進行にかかわる細菌を制御するこ
とは歯周病の治療において有効な手段である。歯周病,
歯肉炎の発症に大きく関与している各種口腔内細菌の生
育を阻害する薬剤としてはクロルヘキシジン,トラネキ
サム酸や、テトラサイクリン,ミノサイクリン等の抗生
物質の使用が知られている外、天然物としてはカミツレ
チンキ,ラタニアチンキ,ヒノキチオール等が利用され
ている。(Prior Art) Periodontal disease is caused by progression of gingivitis, and 50% of the causes of tooth loss are periodontal disease. The prevalence of periodontal disease has increased since the late 20s, and approximately 50% of people (80% when gingivitis is involved) are affected by middle and old age. It is generally considered that gram-negative anaerobic bacilli in gingival plaque are deeply involved in the onset and progression of periodontal disease. Especially Bacteroides gingivalis (B. gingivalis), Bacteroides intermedius (B. intermedius), Bacteroides melaninogenicus (B. melaninogenicu)
s), Actinobacillus actinomycetemcomitans, Fusobacterium nucleatu
m) etc. have been suggested to be related to the onset and progression of various types of periodontal disease (Koichi Nakajima et al .: Antibiotic treatment of periodontal disease. Nihon Periodon, Vol. 29, No. 2) 463-471, 1987). Therefore, controlling bacteria involved in the development and progression of periodontal disease is an effective means in treating periodontal disease. Periodontal disease,
The use of antibiotics such as chlorhexidine, tranexamic acid, and tetracycline and minocycline is known as a drug that inhibits the growth of various oral bacteria that are greatly involved in the onset of gingivitis. , Ratania tincture, hinokitiol and the like are used.
(発明が解決しようとする課題) しかしながら、これら公知の口腔内細菌の生育阻害剤
は口の中で使用する場合には安全性に問題があったり、
投与した際不快臭がする等の欠点があった。(Problems to be Solved by the Invention) However, when these known oral bacterial growth inhibitors are used in the mouth, they have safety problems,
There were drawbacks such as an unpleasant odor when administered.
本発明の目的は食品として身近に利用されているもの
から、歯周病菌に対し抗菌性をもち、しかも不快臭のな
いものを選択し、それより成る歯周病菌増殖抑制剤を提
供することにある。An object of the present invention is to select a substance which has antibacterial properties against periodontal disease bacteria and has no unpleasant odor from those commonly used as foods, and to provide a periodontal disease bacterial growth inhibitor comprising the same. is there.
(課題を解決するための手段) 本発明は、ビャクダン,グアヤック,パチュリから選
択される精油成分から成る歯周病菌の増殖抑制剤であ
る。(Means for Solving the Problems) The present invention is a growth inhibitor of periodontal disease bacteria comprising an essential oil component selected from sandalwood, guaiac, and patchouli.
本発明で用いられるビャクダンオイルは公知の化合物
であり、例えばビャクダン科Santalum album L.の根及
び心材を水蒸気蒸留することによって得られる、やや粘
ちょうな黄色の液体で、ソフトな甘いウッディ調の香気
を持つ。The sandalwood oil used in the present invention is a known compound, for example, a slightly viscous yellow liquid obtained by steam distillation of the root and heartwood of the sandalwood family Santalum album L., which has a soft sweet woody aroma. have.
本発明で用いられるグアヤックオイルは公知の化合物
であり、例えば南米で生産されるハマビシ科Bulnesia s
urmienti Lor.の心材を乾燥し、オガクズ状にしたもの
を水蒸気蒸留して得られる(グアヤックウッドオイ
ル)。室温では黄白色の固塊状物質であるが、40〜50℃
に加温することによって粘稠な黄色の液体となる。甘い
ローズ様の香気を有し、フレーバーとして用いられてい
る。The guaiac oil used in the present invention is a known compound, for example, Bulnesia s.
Urmienti Lor. can be obtained by drying the heartwood and making it into a sawdust form by steam distillation (guaiac wood oil). At room temperature is a yellow-white solid mass, but 40-50 ° C
To a viscous yellow liquid. It has a sweet rose-like aroma and is used as a flavor.
本発明で用いられるパチュリオイルは公知の化合物で
あり、例えばシソ科の多年生草木であるPatchouly(パ
チュリ)の葉の乾燥物を粉砕し、水の飲料のフレーバー
として一般に用いられている。The patchouli oil used in the present invention is a known compound, and is generally used as a flavor of water drinks by crushing dried leaves of Patchouly, a perennial plant of the Labiatae family, for example.
本発明の歯周病菌の増殖抑制剤の投与形態としては口
腔中で比較的滞留時間の長いチューインガム,キャンデ
ィー等の食品に配合させることによりその効果が期待で
きる。その配合量は食品の形態,種類等によって必ずし
も一様ではないがその食品中0.003〜5重量%、好まし
くは0.1〜1重量%配合するのが一般的である。またそ
れらは単独で用いても混合で用いてもよい。The dosage form of the periodontal disease growth inhibitor of the present invention can be expected to be effective when incorporated into foods such as chewing gum and candy which have a relatively long residence time in the oral cavity. The compounding amount is not necessarily uniform depending on the form and type of the food, but it is generally 0.003 to 5% by weight, preferably 0.1 to 1% by weight in the food. They may be used alone or as a mixture.
また食品に限らず、歯磨,洗口液等にも適用が可能で
あり、歯周病の治療への応用が期待できる。Further, the present invention can be applied not only to food but also to toothpaste, mouthwash, and the like, and is expected to be applied to treatment of periodontal disease.
以下に実施例を挙げて、本発明を更に詳細に説明す
る。Hereinafter, the present invention will be described in more detail with reference to Examples.
(実施例) 実施例に先立って歯周病菌に対する抗菌活性の試験方
法について説明する。(Example) Prior to an example, a test method of antibacterial activity against periodontal disease bacteria will be described.
抗菌活性試験方法 2倍段階希釈により0.02〜4mg/mlに調製した本発明の
歯周病菌増殖抑制剤(以下「試料」とする)各々を含む
変法GAM寒天培地(日水製薬製)に、予めGAMブイヨン培
地(日水製薬製)にて37℃,24時間嫌気培養した被験菌
を1白金耳摂取し、37℃で5日間嫌気培養した後、菌の
生育の有無を肉眼で判定した。Antibacterial activity test method A modified GAM agar medium (manufactured by Nissui Pharmaceutical Co., Ltd.) containing each of the periodontal disease growth inhibitor (hereinafter referred to as “sample”) of the present invention prepared to 0.02 to 4 mg / ml by two-fold serial dilution, One platinum loop of a test bacterium that had been anaerobically cultured at 37 ° C. for 24 hours in a GAM broth medium (manufactured by Nissui Pharmaceutical Co., Ltd.) was ingested and anaerobically cultured at 37 ° C. for 5 days, and then the presence or absence of growth of the bacterium was visually determined.
完全に生育が阻止されている平板に含まれている試料
の最低濃度をもって、最小生育阻止濃度(mg/ml)とし
た。The minimum concentration of the sample contained in the plate where growth was completely inhibited was defined as the minimum growth inhibition concentration (mg / ml).
尚、被験菌としては、バクテロイデス・ジンジバリス
(Bacteroides gingivalis)ATCC33277株,バクテロイ
デス・インターメディウス(B.intermedius)ATCC15032
株,バクテロイデス・メラニノジェニカス(B.melanino
-genicus)ATCC25845株,アクチノバシラス・アクチノ
マイセテムコミタンス(Actinobacillus actinomycetem
comitans)ATCC29522株,フゾバクテリウム・ヌクレア
タム(Fusobacterium nucleatum)ATCC10953株を使用し
た。In addition, Bacteroides gingivalis (Bacteroides gingivalis) ATCC33277 strain and Bacteroides intermedius (B. intermedius) ATCC15032 were used as test bacteria.
Bacteroides melaninogenikas (B. melanino
-genicus) ATCC25845 strain, Actinobacillus actinomycetem
comitans) ATCC29522 strain and Fusobacterium nucleatum ATCC10953 strain were used.
実施例1 ビャクダンオイル ビャクダンの材部及び根部の細断物200gを、1の水
と共に約50時間水蒸気蒸留し、精油を約10g得た。Example 1 Sandalwood oil 200 g of shredded sandalwood material and roots were subjected to steam distillation with 1 piece of water for about 50 hours to obtain about 10 g of essential oil.
これを試料として、前述の方法にて抗菌活性試験を行
い、結果を第1表に示した。Using this as a sample, an antibacterial activity test was performed by the method described above, and the results are shown in Table 1.
実施例2 グアヤックウッドオイル ハマビシ科Bulnesia surmienti Lor.の心材を乾燥し
たもの200gを粉砕し、1の水と共に約50時間水蒸気蒸
留し、精油を約8g得た。Example 2 Guaiac wood oil 200 g of dried heartwood of Tribulus terrestris Bulnesia surmienti Lor. Was pulverized and steam-distilled with 1 piece of water for about 50 hours to obtain about 8 g of an essential oil.
これを試料として、前述の方法にて抗菌活性試験を行
い、結果を第1表に示した。Using this as a sample, an antibacterial activity test was performed by the method described above, and the results are shown in Table 1.
実施例3 パチュリオイル シソ科パチュリの葉の乾燥物200gを細断し、1の水
と共に約8時間水蒸気蒸留し、精油を約4g得た。Example 3 Patchouli oil 200 g of dried patchouli leaves were cut into small pieces and steam-distilled with 1 piece of water for about 8 hours to obtain about 4 g of essential oil.
これを試料として、前述の方法にて抗菌活性試験を行
い、結果を第1表に示した。Using this as a sample, an antibacterial activity test was performed by the method described above, and the results are shown in Table 1.
第1表の結果から各種香料は菌の増殖抑制に優れた効
果を示すことは明らかである。 From the results shown in Table 1, it is clear that various flavors show an excellent effect on inhibiting the growth of bacteria.
以下に、本発明の歯周病菌の増殖抑制剤の、食品への
応用例を示す。Hereinafter, application examples of the growth inhibitor of periodontal disease bacteria of the present invention to foods will be described.
応用例−1(チューインガムの製造)配合組成 重量% チューインガムベース 20.0 粉糖 51.9 ブドウ糖 10.0 水飴 18.0ビャクダンオイル 0.1 製法 40℃に保温した全量のチューインガムベース及び全量
の水飴をニーダーに投入して10分間混練し粉糖の1/3量
及び全量のブドウ糖を投入して5分間、次いで粉糖の1/
3量を投入して5分間混練した。次に、増殖抑制剤であ
るビャクダンオイルを残りの1/3量の粉糖に混合してか
ら投入し5分間混練してガムミックスを得た。Application Example-1 (Manufacture of chewing gum) Formulation composition% by weight chewing gum base 20.0 Powdered sugar 51.9 Glucose 10.0 Ginger syrup 18.0 Sandalwood oil 0.1 Production method All the chewing gum base and all syrup candy kept at 40 ° C are put into a kneader and kneaded for 10 minutes. 1/3 of the powdered sugar and the whole amount of glucose are charged for 5 minutes, then 1/3 of the powdered sugar
Three amounts were charged and kneaded for 5 minutes. Next, sandalwood oil, which is a growth inhibitor, was mixed with the remaining 1/3 amount of powdered sugar, added, and kneaded for 5 minutes to obtain a gum mix.
応用例−2(チューインガムの製造) 製法 応用例−1のビャクダンオイルの代わりにグアヤック
ウッドオイル0.2重量%を用い、粉糖を51.8重量%にし
た他は応用例−1と同様行ないガムミックスを得た。Application Example 2 (Manufacture of chewing gum) Production Method A gum mix is obtained in the same manner as in Application Example 1 except that guaiac wood oil is used in an amount of 0.2% by weight in place of sandalwood oil of Application Example 1 and the powdered sugar is 51.8% by weight. Was.
応用例−3(チューインガムの製造) 製法 応用例−1のビャクダンオイルの代わりにパチュリオ
イル0.2重量%を用い、粉糖を51.8重量%にした他は応
用例−1と同様行ないガムミックスを得た。Application Example-3 (Manufacture of chewing gum) Production method A gum mix was obtained in the same manner as in Application Example-1, except that 0.2% by weight of patchouli oil was used instead of sandalwood oil of Application Example-1 and powdered sugar was changed to 51.8% by weight. .
応用例−4(チューインガムの製造) 製法 応用例−1のビャクダンオイルの代わりにビャクダン
オイル,カッシャオイル,シンナモンオレオレジン,グ
アヤックウッドオイル,パチュリオイルを各々0.1重量
%混合したもの0.5重量%を用い、粉糖を51.5重量%に
した他は応用例−1と同様行ないガムミックスを得た。Application Example-4 (Manufacture of chewing gum) Production Method Instead of sandalwood oil of application example-1, 0.5% by weight of each of 0.1% by weight of sandalwood oil, cascia oil, cinnamon oleoresin, guaiac wood oil and patchouli oil was used. A gum mix was obtained in the same manner as in Application Example 1 except that powdered sugar was changed to 51.5% by weight.
応用例−5(キャンディーの製造)配合組成 重量部 グラニュー糖 60.3 水飴(水分30%) 56.0 クエン酸 0.3 クチナシ色素 0.1ビャクダンオイル 0.1 製法 予備溶解釜に、グラニュー糖,水飴及び小量の水を投
入し、一度沸騰させてグラニュー糖を完全に溶解し、こ
の混合物を真空クッカーにポンプで送り込み、真空度46
0mmHg,温度130℃で煮詰めた後、取出釜に取り混合釜に
移した。次いで増殖抑制組成物であるビャクダンオイ
ル,クエン酸及びクチナシ色素を投入して十分混合後、
冷却盤上に広げキャンディーマスを得た。Application Example-5 (Manufacture of candy) Formulation composition parts by weight granulated sugar 60.3 starch syrup (30% moisture) 56.0 citric acid 0.3 gardenia pigment 0.1 sandalwood oil 0.1 manufacturing method Into a pre-dissolution pot, put granulated sugar, starch syrup and a small amount of water. Bring to a boil once to completely dissolve the granulated sugar and pump this mixture into a vacuum cooker to a degree of vacuum of 46.
After boiling down at 0 mmHg and a temperature of 130 ° C., the mixture was taken into a take-out pot and transferred to a mixing pot. Then, after adding the sandalwood oil, citric acid and gardenia pigment, which are growth-inhibiting compositions, and mixing well,
Spread out on the cooling board to get candy mass.
応用例−6(キャンディーの製造) 製法 応用例−5のビャクダンオイルの代わりにグアヤック
ウッドオイルを0.2重量部を用い、グラニュー糖を60.2
重量部用いた他は応用例−5と同様行ないキャンディー
マスを得た。Application Example-6 (manufacture of candy) Manufacturing method 0.2 parts by weight of guaiac wood oil instead of sandalwood oil of application example-5 and 60.2 parts of granulated sugar
A candy mass was obtained in the same manner as in Application Example-5 except that the parts by weight were used.
応用例−7(キャンディーの製造) 製法 応用例−5のビャクダンオイルの代わりにパチュリオ
イルを0.2重量部用い、グラニュー糖を60.2重量部用い
た他は応用例−5と同様行ないキャンディーマスを得
た。Application Example-7 (Manufacture of candy) Production method A candy mass was obtained in the same manner as in Application Example-5 except that 0.2 parts by weight of patchouli oil and 60.2 parts by weight of granulated sugar were used instead of sandalwood oil of Application Example-5. .
応用例−8(キャンディーの製造) 製法 応用例−5ビャクダンオイルの代わりにビャクダンオ
イル,カッシャオイル,シンナモンオレオレジン,グア
ヤックウッドオイル,パチュリオイルを各々0.1重量部
混合したもの0.5重量部を用い、グラニュー糖を59.9重
量部用いた他は応用例−5と同様行ないキャンディーマ
スを得た。Application Example-8 (Manufacture of Candy) Manufacturing Method Application Example-5 Instead of sandalwood oil, 0.5 parts by weight of 0.1 part by weight each of sandalwood oil, cascia oil, cinnamon oleoresin, guaiac wood oil, and patchouli oil were used. A candy mass was obtained in the same manner as in Application Example-5 except that 59.9 parts by weight of granulated sugar was used.
これらのチューインガム・キャンディーには不快臭は
なかった。These chewing gum candies had no unpleasant odor.
(発明の効果) 本発明の歯周病菌の増殖抑制剤は、歯を失う原因とな
る歯周病菌の増殖を効果的に阻止する。また従来知られ
ている同菌の増殖抑制物質に共通してみうけられる不快
臭が全くなく、食品その他の口腔用組成物に利用するの
に適している。(Effect of the Invention) The growth inhibitor of periodontal disease bacteria of the present invention effectively inhibits the growth of periodontal disease bacteria that cause tooth loss. Further, it has no unpleasant odor commonly found in conventionally known growth inhibitory substances of the same bacterium, and is suitable for use in foods and other oral compositions.
フロントページの続き 合議体 審判長 加藤 孔一 審判官 宮本 和子 審判官 谷口 浩行 (56)参考文献 特開 昭59−175410(JP,A) 特開 平3−255031(JP,A)Continuing from the front page Judge of the Joint Panel Koichi Kato Judge Kazuko Miyamoto Judge Hiroyuki Taniguchi (56) References JP-A-59-175410 (JP, A) JP-A-3-255031 (JP, A)
Claims (1)
択される精油成分から成る歯周病菌の増殖抑制剤。1. A growth inhibitor of periodontal disease bacteria comprising an essential oil component selected from sandalwood, guaiac and patchouli.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2126331A JP2582736B2 (en) | 1990-05-15 | 1990-05-15 | Periodontal disease growth inhibitor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2126331A JP2582736B2 (en) | 1990-05-15 | 1990-05-15 | Periodontal disease growth inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0421634A JPH0421634A (en) | 1992-01-24 |
| JP2582736B2 true JP2582736B2 (en) | 1997-02-19 |
Family
ID=14932543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2126331A Expired - Fee Related JP2582736B2 (en) | 1990-05-15 | 1990-05-15 | Periodontal disease growth inhibitor |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2582736B2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0645549B2 (en) * | 1990-05-24 | 1994-06-15 | 株式会社ロッテ | Anti periodontal drug |
| EP1184030A1 (en) * | 2000-08-14 | 2002-03-06 | Givaudan SA | Antibacterial composition comprising trimethylnorbornanylcyclohexanol derivatives |
| EP1181866A1 (en) * | 2000-08-14 | 2002-02-27 | Givaudan SA | Antibacterial composition comprising Sandela |
| KR100611248B1 (en) * | 2004-01-05 | 2006-08-10 | 주식회사 내츄로바이오텍 | Antimicrobial and Antifungal Compositions Comprising Plant Essential Oils |
| JP2006298824A (en) * | 2005-04-21 | 2006-11-02 | Kao Corp | Inhibitor for skatole production in oral cavity |
| JP2006347947A (en) * | 2005-06-15 | 2006-12-28 | Seiko Awane | Antibacterial agent containing extract of prunus mume flesh |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59175410A (en) * | 1983-03-26 | 1984-10-04 | Kanebo Shokuhin Kk | Cariostatic agent |
| JPH03255031A (en) * | 1990-03-02 | 1991-11-13 | Taiyo Koryo Kk | Periodontosis preventing composition |
-
1990
- 1990-05-15 JP JP2126331A patent/JP2582736B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0421634A (en) | 1992-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0125282B1 (en) | Chewing gum for preventing pyorrhea alveolaris | |
| EP1605909A1 (en) | Flavoured mouth wash composition | |
| JP4127875B2 (en) | Anti-Helicobacter pylori | |
| JPH0140005B2 (en) | ||
| JP2582736B2 (en) | Periodontal disease growth inhibitor | |
| JPH07316064A (en) | Inhibitors for periodontal disease-causing bacteria or caries-causing bacteria, and oral compositions and foods containing them | |
| JPS61171423A (en) | Drug for alleviating dental caries and periodontosis | |
| JPS63211219A (en) | Preventive for dental caries | |
| JPWO2004026273A1 (en) | Oral composition | |
| JP2019094269A (en) | Compositions for inhibiting periodontal bacterial growth | |
| JPH0466523A (en) | Agent for suppressing proliferation of pathogen of periodontosis | |
| JPH03255031A (en) | Periodontosis preventing composition | |
| KR20190095156A (en) | Composition for preventing or treating periodontal disease and dental caries containing fluoride varnish and antibacterial agents as an active ingredient | |
| JP5091426B2 (en) | Anti-periodontal agent, food and drink or oral hygiene agent containing the anti-periodontal agent | |
| CN108721180B (en) | Bacteriostatic oral composition containing honeysuckle, product and preparation method thereof | |
| JP2582736C (en) | ||
| KR102149516B1 (en) | Compositions for preventing or treating oral diseases using omija and banana extract | |
| JPH0687752A (en) | Antibacterial water and method for producing this antibacterial water | |
| JP2023065037A (en) | oral composition | |
| KR20230046792A (en) | COMPOSITION FOR PREVENTING BIOFILM FORMATION COMPRISING EXTRACT OF Piperis Nigri Fructus | |
| JP6389212B2 (en) | Oral composition | |
| JP7770525B2 (en) | solid food | |
| JP7725198B2 (en) | Agents for preventing or improving periodontal disease | |
| JPH0627067B2 (en) | Oral composition | |
| WO2026029189A1 (en) | Microbiota improving agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081121 Year of fee payment: 12 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081121 Year of fee payment: 12 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081121 Year of fee payment: 12 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081121 Year of fee payment: 12 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081121 Year of fee payment: 12 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| LAPS | Cancellation because of no payment of annual fees |